Updated: May 1, 2009
Facial nerve denervation and paralysis imposes significant psychological and functional impairment. Facial paralysis can inhibit and mar facial expression, communication, symmetrical smile, eye protection, and oral competence. Myriad modalities and stratagems exist for each patient; the physician must accurately evaluate and examine the patient and determine the etiology, duration, and the scale of the paralysis. Understanding facial nerve anatomy with precise assessment of the patient's paralysis and health status dictates the potential for recovery and the most appropriate reconstructive scheme.
The goals of the reconstruction in facial paralysis include the following:
The precentral gyrus emits the voluntary motor portion of the facial nerve, where most of these nerve fibers cross in the pontine region to approach the facial nerve nucleus in the contralateral pons. At the cerebellopontine angle (CPA), the facial nerve is near the nervus intermedius and the eighth cranial nerve.
Intratemporal facial nerve
The first branch of the facial nerve is the greater petrosal nerve, which departs from the geniculate ganglion and is responsible for parasympathetic secretion of the nose, mouth, and lacrimal gland. The nerve to the stapedius is the next branch and arises from the proximal mastoid segment. The chorda tympani nerve emerges proximal to the stylomastoid foramen and carries parasympathetic secretory fibers to the submandibular and sublingual glands as well taste fibers to the anterior two thirds of the tongue.
Extratemporal facial nerve
The extratemporal branching of the facial nerve has myriad patterns and variations. Dingman and Grabb present the largest series of the surgical anatomy of the marginal mandibular branch,[1 ]while Pitanguy identifies the course of the temporal branch.[2 ]
The facial nerve innervates a total of 23 paired muscles and the orbicular oris, but only 18 of these muscles, working in a delicate balance, produce facial animation and expression. No current reconstructive stratagem can reproduce every facial expression and movement.
Evaluation of a patient with facial paralysis commences with a thorough and detailed history and physical examination. Etiology is the most important factor in determining the timing and choice of reconstructive technique. Reconstructive efforts should not commence prior to establishing the etiology of the paralysis.
A thorough history includes onset, initial degree of paralysis, duration, and associated symptoms. These details often can help identify the etiology. Facial nerve injuries from Bell palsy, trauma, and malignant neoplasm need to be identified. The reconstructive efforts and interventions need to be tailored appropriately based on the etiology of the disorder.
For example, a slowly progressive paralysis suggests malignancy, while a sudden onset of complete paralysis suggests Bell palsy. The workup, treatment, and prognosis of these 2 disorders differ vastly from one another. If a tumor is suspected, proper evaluation of the patient is of the utmost importance to appropriately treat the malignancy and choose the best reconstructive option. If paralysis is caused by a malignancy or is a result of resection for a malignancy, the risk of recurrence and prognosis may influence the choice of reconstruction. Malignancy of the posterior fossa, temporal bone, skull base, or parotid region can present with facial paralysis.
Bell palsy is an idiopathic form of facial paralysis and is a diagnosis of exclusion. Trauma is the second most common cause of facial paralysis. Eighty percent of patients with facial paralysis suffer from Bell palsy. Eighty-five percent of these patients begin to recover nerve function spontaneously within 3 weeks of onset; the other 15% do not have any movement for 3-6 months. If the patient has Bell palsy, the potential for complete recovery is excellent, especially in incomplete paralysis. Peitersen found 94% of patients with partial paralysis completely recovered facial nerve function in 1 year without medical or surgical intervention; of those with complete paralysis, 71% completely recovered.[3 ]Therefore, irreversible techniques to reanimate the face may not be the best choice in these patients.
The etiology of the denervation also dictates the timing of surgical treatment, if any is to be done. In a patient with a paralyzed face secondary to traumatic surgical disruption, the surgeon should initiate reconstruction as soon as possible, generally within the first month. On the other hand, a patient with an intact nerve can be monitored for recovery for up to 12 months. The duration of the facial paralysis is essential. The reconstructive options for acute paralysis, paralysis for less than 18-24 months, and paralysis for greater than 18-24 months differ significantly.
In addition, the surgical team must investigate previous surgical procedures for reanimation, since these may limit reconstructive options. The patient's overall health, psychological stability, and life expectancy are significant considerations. Patients with significant health risks and medical problems are not appropriate candidates for invasive reconstructive operations, the results of which do not manifest for 2-3 years postoperatively. The patient and the surgeon should thoroughly discuss the patient's expectations. As part of patient education, surgeons need to establish realistic expectations and determine whether the patient is willing to expend the time and financial resources required for a successful result.
The surgeon must perform a comprehensive physical examination of the patient with facial paralysis, scrutinizing the face at rest and during voluntary and reflex emotional movement. The physician must determine the involvement of unilateral or bilateral facial nerves, facial asymmetries, and synkinesis. The degree of brow ptosis, ectropion, lid laxity, and oral competence must also be noted. The surgical team cannot neglect other cranial nerve or neurologic deficits and soft tissue defects in conjunction with the paralysis.
Audiometry
Audiometric testing, including acoustic reflexes and tympanometry, may be useful in identifying the etiology of facial palsy secondary to retrocochlear pathology or mass lesions of the middle ear.
Radiography
High-resolution CT and MRI scans are essential in the evaluation of a patient with traumatic facial nerve palsy to delineate features of the temporal bone, which may impact the facial nerve. Scans are also used to evaluate patients with possible parotid, skull base, temporal bone, intracranial, or extratemporal tumors.
Electrodiagnostic tests of nerve function
Electrodiagnostic tests of facial nerve function include nerve excitability tests (NET), electroneuronography (ENog), and electromyography (EMG). Nerve excitability testing involves percutaneous stimulation of the facial nerve until muscle contraction is observed. The minimal NET determines the threshold stimulation required for muscle contraction compared to the unaffected side. Maximum stimulation test (MST) is a modification of the NET but is a supramaximal stimulus compared to the unaffected side, and the stimulus is increased until the patient encounters discomfort. The subjective nature of the measurements and lack of recorded data limit both methods, and they do not reflect denervation at the moment it is occurring.
Electroneurography (ENog) is an objective measure of facial nerve function that measures the amplitude of evoked compound muscle action potentials (CMAP) with electrodes over the skin of the nasolabial fold. The compound action potential is compared between the 2 sides of the face, and the response of the affected side is expressed as a percentage of the response of the unaffected side. A percentage of nerve fiber degeneration is calculated. A 95% decrease in CMAP compared with the contralateral side signifies a 50% chance that the patient will have unsatisfactory recovery of facial nerve function. Surgery is indicated if a 90% decrease in CMAP is reached within the initial 2 weeks of the onset of paralysis. ENog is objective and is the most accurate reproducible test, but it is expensive and time-consuming.
EMG is a measure of volitional muscle response unlike the other modalities. Needle electrodes are used to monitor activity of the facial muscles. Normal muscle exhibits activity upon needle insertion, electrical silence at rest, and diphasic or triphasic action potentials during voluntary contraction. Fibrillation potentials are observed in the denervated muscle, and polyphasic potentials are observed in muscle undergoing reinnervation. Complete electrical silence is observed in denervated muscle with significant fibrosis. EMG is useful in evaluating patients with acute or traumatic nerve injury and in assessing the viability of the facial musculature when evaluating patients for reinnervation procedures. EMG does not show any signs until 3 weeks after paralysis and should not be utilized until 3 weeks after facial paralysis without any signs of recovery.
Objective measures of facial motion
Objective measures of facial motion include digital photography and video recording of the patient and rest and during motion. Dated visual documentation and preoperative and postoperative facial function is salient for preoperative planning and outcome assessment.
A recently developed method of objective measurement is the maximum static response assay of facial motion. This method quantifies facial motion preoperatively and serially during the postoperative period. Mark the patient's face and ask him or her to perform region-specific movements, including brow lift, eye closure, smiling, frowning, and whistling or puckering. The images of the face in repose and the maximum response movements are recorded and processed for computer display. The images are calibrated and normalized, and vectors of movement are determined and measured using a grid and an internal facial coordinate system. Even slight improvements in facial movement can be detected over the long recovery periods that often accompany facial reanimation procedures.
Patients desire a countenance and visage with a normal or almost normal balance when the person's face is at rest. Objectives of treatment are corneal protection, establishing a normal resting tone, and, most importantly, restoring a symmetrical dynamic smile.
Little information is available on the denervation of human facial muscles. Denervated muscles cannot be voluntarily stimulated and has no response to electrical stimulation. A longer period of denervation translates into a lesser degree of recovery after reinnervation. There is a decrease in efficiency of muscle reinnervation after 12-18 months of paralysis/denervation. Muscles that are reinnervated may not undergo full recovery nor respond to regenerated nerves.
Repair of the facial nerve is the most effective procedure to restore the function of the face. Repair is indicated in patients who have experienced acute disruption or transection of the nerve from an accident, trauma, resection during extirpation, or inadvertent division during surgery.
Nerve substitution via grafting or nerve transfer should be achieved in patients with facial paralysis who lack the proximal nerve segment but have an intact distal neuromuscular pathway, including an intact distal segment of nerve and facial musculature suitable for reinnervation. A donor nerve, transferred and anastomosed to the distal facial nerve stump, innervates the facial muscles in place of the injured proximal facial nerve.
The spinal accessory, phrenic, and trigeminal nerves have been used in nerve transfer procedures. However, sacrificing these nerves involves significant morbidities. Therefore, the hypoglossal nerve transfer/graft and cross-facial grafting have remained the mainstays in treatment.
When facial nerve dysfunction has exceeded 18 months, dynamic slings and free muscle transfers can be executed to restore facial and oral motor function. Severe neurofibrosis and myofibrosis in the distal neuromuscular unit preclude successful reinnervation. Patients with congenital facial paralyses cannot be reinnervated, since the neuromuscular units never developed. Regional muscle transposition and free-muscle transfer are the 2 modalities to reanimate the face in this subset of patients.
Regional muscle transfer can reanimate the lower third of the paralyzed face. This new neuromuscular unit is composed of the transferred muscle (to its new origin) with its original nerve and vascular supply.
Temporalis
The temporalis muscle may improve the symmetry of the commissure of the mouth and reestablish a voluntary smile. The vector of the temporalis muscle resembles that of the zygomaticus major and, thus, results in a lateral smile.
Temporalis muscle transposition can also reanimate the eyelids. Reanimation of the eye with the temporalis transfer can produce eyelid distortion. To avoid a contour defect, do not use the muscle anterior to the hairline. Transposition will not produce spontaneous mimetic function. Each movement necessitates a specific volitional action, in which the patient must consciously contract the transposed muscle in conjunction with the smiling. Reanimation of the eye with the temporalis muscle can cause eyelid distortion.
The muscle is harvested through a vertical incision in front of the ear that extends to the scalp. The middle section of the muscle and fascia is elevated and detached superiorly from the skull while preserving the inferior attachments. Two tongues are creating by bisecting the muscle, and the muscle is tunneled through a subcutaneous pocket from the zygomatic arch to the vermillion border. The ends of the temporalis are secured to the orbicularis and the corner of the mouth. The ends should be secured with enough tension to create some level of overcorrection. The patient initiates a smile by consciously tensing the temporalis muscle. Patients will require therapy to master this technique.
In his study, May reports improvement in 95% of patients with temporalis transfer for lower face reanimation and good-to-excellent results in 78% of patients. The complication rate was 18%; the most common complications were infection and implant-related complications. Other potential complications include failure of attachment, pulling away of the temporalis muscle from the commissure, and overcorrection of the upper lip. The transfer may also generate excess muscle bulk and a facial deformity, particularly over the zygoma.
Masseter
The masseter muscle is another muscle used for reanimation of the commissure of the mouth, either alone or in conjunction with the temporalis. Unlike the temporalis, the vector of smile of the masseter muscle is in the buccinator-risorius direction, which produces a less natural smile. This muscle is elevated by detaching the anterior portion from its mandibular insertion. It is similarly bisected and secured to the modiolus. The muscle is quite bulky and can create facial irregularity or surface deformity, such as a bulge at the commissure. Postoperatively, patients must train the masseter with aggressive physical therapy to learn how to use the transposed masseter to produce a smile.
Digastric
The smile is one of the most important facial expressions, and facial paralysis can debilitate an individual. Conley developed the modern method of transposing the tendon of the digastric muscle to the orbicularis of the lower lip. The blood supply and nerve to the anterior belly remains intact, and dynamic depression of the lower lip border is achieved. Of 36 patients treated in this manner by Conley, 33 were reported to have satisfactory results. This method is ideal for isolated palsy of the marginal mandibular nerve only, since it can create oral incompetence in patients with more extensive palsy of the lower face.
Depressor muscle function is important to dentured smile as well as to expressions of sadness, anger, and sorrow. The lower lip is animated by interactions of the orbicularis ori, depressor labii inferioris, depressor anguli oris, mentalis, and platysma. Terzis describes a technique to improve this type of smile by transfer either of the anterior belly of the digastric tenor or of the platysma.[11 ]Other authors argue that this symmetrical smile could be achieved with less invasive approaches, including BOTOX® injections or myectomy of the depressor labii inferioris.
Regional muscle transposition is limited by anatomic constraints of size and vectors and often produces results slightly better than static strategies. Regional muscle procedures are appropriate in patients who are in poor health or who will not survive beyond the 12-24 month period of neurotization of a free muscle transfer. Such procedures provide immediate reanimation and are technically less demanding than cross-facial nerve grafting with free muscle transfer.
Mobius syndrome involves bilateral facial nerve paralysis and can often attack cranial nerves VI, III, and XII. The syndrome generates psychological disability due to lack of facial animation and lack of emotional expression. Patients with immobile faces cannot use their faces to show happiness, sadness, or anger.
The surgical goals for patients with Mobius syndrome are far more modest than and differ from the goals for patients who have unilateral developmental facial paralysis. The restoration of a true smile in these mask-like faces is impossible. Movement can only be restored along one vector. A detailed neurological evaluation can identify possible motor donors or residual function, which can be used for additional dynamic restorations. Because of cranial nerve involvement, a thorough clinical and electrophysiological examination is obligatory.
Most frequently, the reconstructive surgeon performs free tissue transfers with bilateral gracilis muscles anastamosed to the masseter nerves on both sides in order to achieve smile restoration.
Rehabilitation
After surgery, the rehabilitation of patients with facial paralysis necessitates electromyography (EMG) protocols, behavioral modification, and patient exercises. The patient needs to obtain voluntary control of facial regions. Another adjuvant therapy is the use of percutaneous electrical stimulation to stimulate motor function.
Revisions
In their patient population of 486 patients and 183 revisions, Takushima and Harii analyzed excessive muscle bulk and dislocation of the transferred free muscle.[17 ]They determined that predicting muscle bulkiness to obtain symmetry of facial contour is difficult during the initial free-muscle transfer. Their study illustrates the wide gamut of revisions, including muscle debulking of cheek, adjusting tension and attachments of transferred free muscle, and lipoinjection to the cheek for better volume symmetry.
The patient with facial paralysis presents a daunting challenge to the reconstructive surgeon. A thorough evaluation, including complete history and careful physical examination, directs the surgeon to the appropriate treatment modality. Dynamic reanimation involves nerve repair, nerve transfer, regional muscle transfer, or free-muscle transfer. None of the procedures can restore all of the complex vectors and balance of facial movement and expression. However, dynamic reconstructive techniques can yield improved facial symmetry, spontaneous and symmetric smile, eye closure and protection, and oral competence, all of which refurbish patients' emotional, psychological, and cosmetic state and disabilities.
Dingman RO, Grabb WC. Surgical anatomy of the mandibular ramus of the facial nerve based on the dissection of 100 facial halves. Plast Reconstr Surg. Mar 1962;29:266-72. [Medline].
Pitanguy I, Ramos AS. The frontal branch of the facial nerve: the importance of its variations in face lifting. Plast Reconstr Surg. Oct 1966;38(4):352-6. [Medline].
Peitersen E. The natural history of Bell's palsy. Am J Otol. Oct 1982;4(2):107-11. [Medline].
Spector JG, Lee P, Peterein J, Roufa D. Facial nerve regeneration through autologous nerve grafts: a clinical and experimental study. Laryngoscope. May 1991;101(5):537-54. [Medline].
House WF. Acoustic neuroma. Case summaries. Arch Otolaryngol. Dec 1968;88(6):586-91. [Medline].
Arriaga MA, Brackmann DE. Facial nerve repair techniques in cerebellopontine angle tumor surgery. Am J Otol. Jul 1992;13(4):356-9. [Medline].
Chang CY, Cass SP. Management of facial nerve injury due to temporal bone trauma. Am J Otol. Jan 1999;20(1):96-114. [Medline].
Green JD Jr, Shelton C, Brackmann DE. Iatrogenic facial nerve injury during otologic surgery. Laryngoscope. Aug 1994;104(8 Pt 1):922-6. [Medline].
Korte W. Ein Fal von Nerven Fropfung: des Nervus facialis auf den Nervus hypoglossus. Dtsch Med Wochenschr. 1903;29:293.
Schaitkin BM. Nerve substitution techniques: XII-VII hook-up, XII-VII jump graft, and cross-facial graft. In: May M. The Facial Nerve: May's Second Edition. New York: Thieme Medical Publishers; 2000:611-33.
Terzis JK, Kalantarian B. Microsurgical strategies in 74 patients for restoration of dynamic depressor muscle mechanism: a neglected target in facial reanimation. Plast Reconstr Surg. May 2000;105(6):1917-31; discussion 1932-4. [Medline].
Harii K, Ohmori K, Torii S. Free gracilis muscle transplantation, with microneurovascular anastomoses for the treatment of facial paralysis. A preliminary report. Plast Reconstr Surg. Feb 1976;57(2):133-43. [Medline].
Lifchez SD, Gasparri MG, Sanger JR, et al. Serratus anterior in vivo contractile force study. Plast Reconstr Surg. Sep 2005;116(3):839-45. [Medline].
Terzis JK, Noah ME. Analysis of 100 cases of free-muscle transplantation for facial paralysis. Plast Reconstr Surg. Jun 1997;99(7):1905-21. [Medline].
O'Brien BM, Pederson WC, Khazanchi RK, et al. Results of management of facial palsy with microvascular free-muscle transfer. Plast Reconstr Surg. Jul 1990;86(1):12-22; discussion 23-4. [Medline].
Kumar PA, Hassan KM. Cross-face nerve graft with free-muscle transfer for reanimation of the paralyzed face: a comparative study of the single-stage and two-stage procedures. Plast Reconstr Surg. Feb 2002;109(2):451-62; discussion 463-4. [Medline].
Takushima A, Harii K, Asato H, Momosawa A. Revisional operations improve results of neurovascular free muscle transfer for treatment of facial paralysis. Plast Reconstr Surg. Aug 2005;116(2):371-80. [Medline].
Adkins WY, Osguthorpe JD. Management of trauma of the facial nerve. Otolaryngol Clin North Am. Jun 1991;24(3):587-611. [Medline].
Aviv JE, Urken ML. Management of the paralyzed face with microneurovascular free muscle transfer. Arch Otolaryngol Head Neck Surg. Sep 1992;118(9):909-12. [Medline].
Bae YC, Zucker RM. A comparison of commissure excursion following gracilis muscle transplantation for facial paralysis using a cross face nerve graft versus the motor nerve to the Masseter nerve. Plastic and Reconstructive Surgery. 2006;117 (7):2407-13.
Baker D. Hypoglossal facial nerve anastomosis indications and limitations. In: Proceedings of the Fifth International Symposium on the Facial Nerve. 1985:526-529.
Baker DC, Conley J. Facial nerve grafting: a thirty year retrospective review. Clin Plast Surg. Jul 1979;6(3):343-60. [Medline].
Barrs DM. Facial nerve trauma: optimal timing for repair. Laryngoscope. Aug 1991;101(8):835-48. [Medline].
Casler JD, Conley J. Simultaneous "dual system" rehabilitation in the treatment of facial paralysis. Arch Otolaryngol Head Neck Surg. Dec 1990;116(12):1399-403. [Medline].
Conley J. Search for and identification of the facial nerve. Laryngoscope. Jan 1978;88(1 Pt 1):172-5. [Medline].
Conley J, Baker DC, Selfe RW. Paralysis of the mandibular branch of the facial nerve. Plast Reconstr Surg. Nov 1982;70(5):569-77. [Medline].
Cross JP Jr. Unilateral neurilemmomas of the eighth cranial nerve: then and now. Am J Otol. Jul 1981;3(1):28-34. [Medline].
Ellis JC, McCaffrey TV. Nerve grafting. Functional results after primary vs delayed repair. Arch Otolaryngol. Dec 1985;111(12):781-5. [Medline].
Fisch U. Facial paralysis in fractures of the petrous bone. Laryngoscope. Dec 1974;84(12):2141-54. [Medline].
Fisch U, Rouleau M. Facial nerve reconstruction. J Otolaryngol. Dec 1980;9(6):487-92. [Medline].
Frey M, Giovanoli P, Tzou CH, Kropf N, Friedl S. Dynamic reconstruction of eye closure by muscle transposition or functional muscle transplantation in facial palsy. Plast Reconstr Surg. Sep 15 2004;114(4):865-75. [Medline].
Gavron JP, Clemis JD. Hypoglossal-facial nerve anastomosis: a review of forty cases caused by facial nerve injuries in the posterior fossa. Laryngoscope. Nov 1984;94(11 Pt 1):1447-50. [Medline].
Gidley PW, Gantz BJ, Rubinstein JT. Facial nerve grafts: from cerebellopontine angle and beyond [letter]. Am J Otol. Nov 1999;20(6):781-8. [Medline].
Johnson PJ, Bajaj-Luthra A, Llull R, Johnson PC. Quantitative facial motion analysis after functional free muscle reanimation procedures. Plast Reconstr Surg. Dec 1997;100(7):1710-9; discussion 1720-2. [Medline].
Kamerer DB. Intratemporal facial nerve injuries. Otolaryngol Head Neck Surg. Sep-Oct 1982;90(5):612-5. [Medline].
Koshima I, Tsuda K, Hamanaka T, Moriguchi T. One-stage reconstruction of established facial paralysis using a rectus abdominis muscle transfer. Plast Reconstr Surg. Jan 1997;99(1):234-8. [Medline].
Lifchez SD, Matloub HS, Gosain AK. Cortical adaptation to restoration of smiling after free muscle transfer innervated by the nerve to the masseter. Plast Reconstr Surg. May 2005;115(6):1472-9; discussion 1480-2. [Medline].
Luxford WM, Brackmann DE. Facial nerve substitution: a review of sixty-six cases. Am J Otol. Nov 1985;Suppl:55-7. [Medline].
Lydiatt WM, Sobba-Higley A, Morrow P, Moore GF. Use of electroneuronography in monitoring facial nerve paralysis. Nebr Med J. Aug 1992;77(8):231-4; discussion 235. [Medline].
Marenda SA, Olsson JE. The evaluation of facial paralysis. Otolaryngol Clin North Am. Oct 1997;30(5):669-82. [Medline].
May M, Klein SR. Facial nerve decompression complications. Laryngoscope. Mar 1983;93(3):299-305. [Medline].
May M, Sobol SM, Mester SJ. Managing segmental facial nerve injuries by surgical repair. Laryngoscope. Oct 1990;100(10 Pt 1):1062-7. [Medline].
Pensak ML, Jackson CG, Glasscock ME 3d, Gulya AJ. Facial reanimation with the VII-XII anastomosis: analysis of the functional and psychologic results. Otolaryngol Head Neck Surg. Mar 1986;94(3):305-10. [Medline].
Rubin LR. The anatomy of a smile: its importance in the treatment of facial paralysis. Plast Reconstr Surg. Apr 1974;53(4):384-7. [Medline].
Scaramella LF. Anastomosi trai due nerve faciali. Arch Otologia. 1971;82:209.
Schaitkin BM. Muscle transposition techniques: temporalis, masseter, and digastric. In: May M. The Facial Nerve: May's Second Edition. 2nd. New York: Thieme Medical Publishers; 2000:635-65.
Schaitkin BM. Nerve repair. In: May M. The Facial Nerve: May's Second Edition. New York: Thieme Medical Publishers; 2000:571-609.
Schaitkin BM, Wiet RJ. Trauma to the facial nerve: external, surgical and iatrogenic. In: May M. The Facial Nerve: May's Second Edition. New York: Thieme Medical Publishers; 2000:367-82.
Smith JW. A new technique of facial reanimation. In: Transactions of the 5th International Congress of Plastic and Reconstructive Surgery. 1971:83.
Swartz WM. Free muscle transfer for facial paralysis. In: May M. The Facial Nerve: May's Second Edition. New York: Thieme Medical Publishers; 2000:667-75.
Terris DJ, Fee WE Jr. Current issues in nerve repair. Arch Otolaryngol Head Neck Surg. Jul 1993;119(7):725-31. [Medline].
Terzis JK, Noah EM. Dynamic restoration in Möbius and Möbius-like patients. Plast Reconstr Surg. Jan 2003;111(1):40-55. [Medline].
Terzis JK, Noah EM. Möbius and Möbius-like patients: etiology, diagnosis, and treatment options. Clin Plast Surg. Oct 2002;29(4):497-514. [Medline].
Wei W, Zuoliang Q, Xiaoxi L, et al. Free split and segmental latissimus dorsi muscle transfer in one stage for facial reanimation. Plast Reconstr Surg. Feb 1999;103(2):473-80; discussion 481-2. [Medline].
Wiet RJ. Iatrogenic facial paralysis. Otolaryngol Clin North Am. Nov 1982;15(4):773-80. [Medline].
Zuker RM, Goldberg CS, Manktelow RT. Facial animation in children with Möbius syndrome after segmental gracilis muscle transplant. Plast Reconstr Surg. Jul 2000;106(1):1-8; discussion 9. [Medline].
facial nerve paralysis, facial paralysis, Bells palsy, Bell palsy, facial denervation, facial reinnervation, dynamic reinnervation, paralyzed face, facial symmetry, facial movement, facial expression, synkinesis, facial nerve symmetry, masseter nerve, single-stage, dual-stage, mobius syndrome, Mobius syndrome, facial nerve, symmetrical smile, facial malignancy, progressive paralysis, progressive facial paralysis, sudden facial paralysis, intracranial nerve, masseter muscle, intratemporal nerve, extratemporal nerve, cross facial nerve graft, facial nerve graft, crossfacial nerve graft, cross-facial nerve graft
Alan Bienstock, MD, Consulting Staff, Division of Plastic and Reconstructive Surgery, Department of Surgery, Lennox Hill Hospital, St Luke's/Roosevelt Hospital
Alan Bienstock, MD is a member of the following medical societies: American Medical Association and American Society of Plastic Surgeons
Disclosure: Nothing to disclose.
John YS Kim, MD, Assistant Professor, Department of Surgery, Division of Plastic Surgery, Northwestern Medical Faculty Foundation; Consulting Staff, Northwestern Plastic Surgery
John YS Kim, MD is a member of the following medical societies: American College of Surgeons and American Society of Plastic Surgeons
Disclosure: Nothing to disclose.
Mary C Snyder, MD, Associate Professor, Division of Plastic Surgery, University of Nebraska Medical Center
Mary C Snyder, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Medical Association, and American Rhinologic Society
Disclosure: Nothing to disclose.
Perry J Johnson, MD, Assistant Professor, Department of Plastic and Reconstructive Surgery, University of Nebraska Medical Center
Perry J Johnson, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, and Nebraska Medical Association
Disclosure: Nothing to disclose.
Lawrence Ketch, MD, FAAP, FACS, Head, Program Director, Associate Professor, Department of Surgery, Division of Plastic Surgery, University of Colorado Health Sciences Center; Chief, Pediatric Plastic, The Children's Hospital of Denver
Lawrence Ketch, MD, FAAP, FACS is a member of the following medical societies: American Academy of Pediatrics, American Association for Hand Surgery, American Association of Plastic Surgeons, American Burn Association, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Society for Surgery of the Hand, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, Association for Academic Surgery, and Plastic Surgery Research Council
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Jaime R Garza, MD, DDS, FACS, Consulting Staff, Private Practice
Jaime R Garza, MD, DDS, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Medical Association, American Society for Aesthetic Plastic Surgery, American Society of Maxillofacial Surgeons, Texas Medical Association, and Texas Society of Plastic Surgeons
Disclosure: Allergan Honoraria Consulting
Nicolas (Nick) G Slenkovich, MD, Director, Colorado Plastic Surgery Center
Nicolas (Nick) G Slenkovich, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, and Colorado Medical Society
Disclosure: Nothing to disclose.
Al Aly, MD, FACS, Consulting Surgeon, Iowa City Plastic Surgery
Disclosure: Ethicon Consulting fee Consulting; QMP Royalty Book royalty; Insorb Stapler Consulting fee Consulting; Insorb Stapler Ownership interest None; Medicis Intellectual property rights None
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)